AIDS AND BEHAVIOR, published by SPRINGER/PLENUM PUBLISHERS, is a leading scholarly journal dedicated to the interdisciplinary study of HIV/AIDS, focusing particularly on the behavioral aspects of the epidemic. With an impressive impact factor reflected in its Q1 rankings across key categories including Infectious Diseases, Public Health, and Social Psychology, this journal serves as a vital resource for researchers, clinicians, and public health professionals. It encompasses a wide scope of research, from the psychosocial factors influencing HIV transmission to innovative interventions that promote safe practices. Although it does not offer open access, the journal's rigorous peer-review process ensures the dissemination of high-quality, impactful research. Covering data from 1997 to 2024, AIDS AND BEHAVIOR is positioned at the forefront of advancements in the field, making it an essential addition to any academic library and a must-read for those involved in combating HIV/AIDS.

Statistics in Biopharmaceutical Research, published by Taylor & Francis Inc, is a premier journal that occupies a crucial space in the realms of Pharmaceutical Science and Statistics and Probability. With a robust impact factor affirmed by its Q1 rankings in both categories, the journal stands as a beacon for innovative statistical methodologies and their applications in biopharmaceutical research. Researchers and professionals will find a rich repository of high-quality articles that address contemporary challenges in drug development, clinical trials, and regulatory frameworks. Since its inception in 2011, the journal has continued to foster interdisciplinary collaboration, making significant strides towards enhancing statistical practice in biomedicine. With a commitment to academic rigor and practical relevance, Statistics in Biopharmaceutical Research is an essential resource for anyone looking to advance their understanding and application of statistical techniques in the pharmaceutical industry.

EClinicalMedicine, published by Elsevier, is a leading open-access journal that has been championing the field of medicine since its inception in 2018. With a notable impact factor and a commendable ranking of 16th out of 636 in the category of General Medicine, placing it in the 97th percentile, this journal stands as a pivotal resource for the medical community. The journal encompasses an array of topics within the medicine (miscellaneous) category, fostering interdisciplinary collaboration and advancing research that influences clinical practices worldwide. Researchers, professionals, and students alike can benefit from its robust content, enriched by a Q1 quartile classification in 2023, illustrating its high quality and relevance. As an open-access journal, EClinicalMedicine promotes wider dissemination and accessibility of cutting-edge studies, ensuring that critical findings are available to a global audience. Its address in the United Kingdom positions it at the heart of innovative medical research and practice, making it an excellent platform for those at the forefront of health science advancements.

Reviews on Recent Clinical Trials, published by Bentham Science Publishers Ltd, is a distinguished journal in the medical and pharmacological fields, assessing the latest advancements in clinical research since its inception in 2006. With a focus on integrating multidisciplinary approaches to evaluating clinical trial methodologies, the journal caters to a diverse audience of researchers, professionals, and students keen on enhancing their knowledge and understanding of innovative therapeutic strategies and drug developments. Notably positioned in the Q3 quartile as ranked by Scopus for both 'Medicine (miscellaneous)' and 'Pharmacology', the journal illustrates a growing academic influence, evidenced by its Scopus rankings—holding a commendable 72nd percentile in general medicine and a 33rd percentile in pharmacology. While the journal is not open access, it remains committed to disseminating high-quality, peer-reviewed content that drives forward the conversation in clinical research. For those interested in staying abreast of novel findings and comprehensive reviews within the clinical trial landscape, Reviews on Recent Clinical Trials stands out as an essential resource.

Open Access Journal of Clinical Trials is a premier peer-reviewed journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of clinical pharmacology and medical research. With an impactful open access model initiated in 2009, this journal makes valuable research widely accessible, fulfilling the urgent need for rapid dissemination of scientific knowledge. The journal has established itself as a significant resource in its field, boasting impressive metrics with a 2023 Q2 ranking in Pharmacology (Medical) and a Q1 ranking in the Miscellaneous subsector of Pharmacology, Toxicology, and Pharmaceutics, underscoring its reputation for excellence. Based in New Zealand, the journal fosters global collaboration, and its comprehensive coverage spans various domains within pharmacology and clinical trials. Researchers and practitioners are encouraged to contribute to this vital discourse, as the journal serves as a platform for innovation, collaboration, and the exchange of groundbreaking findings in clinical trials.

Japan Journal of Nursing Science, published by WILEY, serves as a pivotal resource in the field of nursing, focusing on innovative research and theoretical developments that enhance nursing science practices. With an ISSN of 1742-7932, this journal has established itself as a reputable platform, reflected in its 2023 rankings, which place it in the Q2 category for both Medicine (miscellaneous) and Research and Theory. Covering a broad range of topics crucial to the advancement of nursing, the journal provides researchers, professionals, and students access to high-quality studies, methodologies, and discussions that shape contemporary nursing practices and policies. Though not an Open Access journal, it contributes significantly to the academic discourse and research community, with emphasis on fostering evidence-based practices and promoting excellence in nursing education and healthcare delivery. With a cumulative publishing history from 2006 to the present, the Japan Journal of Nursing Science is committed to disseminating vital knowledge that enriches the nursing profession and improves patient care.

Contemporary Clinical Trials Communications, published by ELSEVIER INC, serves as a pivotal resource in the evolving fields of medicine and pharmacology, especially with its commitment to open access since 2015. With the E-ISSN 2451-8654, this journal is dedicated to disseminating high-quality research that examines contemporary clinical trial methodologies and their applications in improving healthcare outcomes. Situated in the United States, its impressive ranking, with a Q2 status in both Medicine (miscellaneous) and Pharmacology for 2023, highlights its significance and impact within the scientific community. Ranking #199 out of 636 in General Medicine and #217 out of 313 in Pharmacology on the Scopus scale, the journal aims to foster innovative discussions and developments among researchers, professionals, and students, making it an essential tool for those seeking to stay at the forefront of clinical research and trials.

Journal of Basic and Clinical Health Sciences, an esteemed publication by DOKUZ EYLUL UNIVERSITY INSTITUTE OF HEALTH SCIENCES, emerges as a crucial platform for disseminating impactful research across the fields of basic and clinical health sciences. With an ISSN of 2458-8938 and E-ISSN of 2564-7288, this journal emphasizes the integration of fundamental and applied research, providing valuable insights into various medical disciplines. Although open access is not indicated, the journal is dedicated to enhancing public health knowledge by publishing high-quality original research, reviews, and case studies. Featuring a commitment to excellence, the Journal of Basic and Clinical Health Sciences aims to bridge the gap between laboratory research and clinical applications, thus playing a vital role in shaping health science education and practice. It serves as an essential resource for researchers, healthcare professionals, and students seeking to contribute to and stay informed about advancements in health sciences.

Rehabilitation Nursing, published by Lippincott Williams & Wilkins, is an esteemed journal dedicated to advancing the fields of rehabilitation, nursing, and physical therapy. With an ISSN of 0278-4807 and an E-ISSN of 2048-7940, this journal has been a crucial resource for practitioners and researchers since its inception in 1975, continuously providing insights through its convergence of scholarship up to 2024. As a member of the Q3 category in multiple disciplines, including Medicine (Miscellaneous), Nursing (Miscellaneous), and Physical Therapy, the journal affirms its relevance within the academic community, particularly highlighted by its Scopus rankings. With a focus on disseminating innovative research, clinical findings, and evidence-based practices, Rehabilitation Nursing aims to enhance patient care and foster improvements in rehabilitation strategies. Whether one seeks to stay abreast of the latest developments or contribute new insights, this journal is a must-read for those involved in the fields of rehabilitation and nursing.

Pilot and Feasibility Studies, published by BMC, stands at the forefront of innovative research in the realm of pilot studies and feasibility assessments, serving as a vital resource for researchers in medicine and healthcare. As an Open Access journal since 2015, it provides unrestricted access to its content, promoting the dissemination of significant findings and fostering collaboration among the global research community. Based in the United Kingdom, this journal has solidly established its reputation, ranking in the Q2 quartile for medicine (miscellaneous) in 2023 with a Scopus rank of #183 out of 398, placing it within the 54th percentile. The journal's scope encompasses a wide range of methodologies and applications, encouraging the translation of pilot studies into viable healthcare practices. With a commitment to quality and accessibility, Pilot and Feasibility Studies plays an essential role in enhancing the rigor and impact of preliminary research, ultimately contributing to the advancement of medical science.